End-of-day quote
Shanghai S.E.
23:00:00 28/04/2024 BST
|
5-day change
|
1st Jan Change
|
31.82
CNY
|
+2.12%
|
|
+0.89%
|
+11.26%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
55,277
|
44,624
|
52,112
|
46,283
|
44,609
|
49,027
|
-
|
-
|
Enterprise Value (EV)
1 |
42,910
|
34,153
|
39,162
|
34,667
|
34,672
|
29,851
|
26,566
|
24,024
|
P/E ratio
|
12.1
x
|
8.93
x
|
7.99
x
|
8.33
x
|
7.92
x
|
7.83
x
|
7.54
x
|
9.66
x
|
Yield
|
2.48%
|
3.36%
|
3.76%
|
3.6%
|
3.79%
|
4.12%
|
4.37%
|
-
|
Capitalization / Revenue
|
0.85
x
|
0.72
x
|
0.76
x
|
0.65
x
|
0.59
x
|
0.61
x
|
0.57
x
|
0.54
x
|
EV / Revenue
|
0.66
x
|
0.55
x
|
0.57
x
|
0.49
x
|
0.46
x
|
0.37
x
|
0.31
x
|
0.26
x
|
EV / EBITDA
|
9.17
x
|
8.34
x
|
7.46
x
|
6.15
x
|
5.93
x
|
5
x
|
4.22
x
|
3.94
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.6
x
|
1
x
|
1.02
x
|
1.03
x
|
0.92
x
|
0.83
x
|
0.76
x
|
0.7
x
|
Nbr of stocks (in thousands)
|
1,625,791
|
1,625,791
|
1,625,791
|
1,625,791
|
1,625,791
|
1,625,791
|
-
|
-
|
Reference price
2 |
23.77
|
16.01
|
18.29
|
20.31
|
19.77
|
19.52
|
19.52
|
19.52
|
Announcement Date
|
31/03/20
|
18/03/21
|
18/03/22
|
17/03/23
|
15/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
64,952
|
61,674
|
69,014
|
70,788
|
75,515
|
80,799
|
85,609
|
90,933
|
EBITDA
1 |
4,681
|
4,097
|
5,249
|
5,639
|
5,842
|
5,974
|
6,301
|
6,092
|
EBIT
1 |
4,055
|
3,672
|
4,786
|
5,074
|
5,121
|
5,314
|
5,426
|
5,676
|
Operating Margin
|
6.24%
|
5.95%
|
6.93%
|
7.17%
|
6.78%
|
6.58%
|
6.34%
|
6.24%
|
Earnings before Tax (EBT)
1 |
4,129
|
3,739
|
4,723
|
5,043
|
5,110
|
5,340
|
5,681
|
5,646
|
Net income
1 |
3,189
|
2,915
|
3,720
|
3,967
|
4,056
|
4,174
|
4,436
|
4,415
|
Net margin
|
4.91%
|
4.73%
|
5.39%
|
5.6%
|
5.37%
|
5.17%
|
5.18%
|
4.86%
|
EPS
2 |
1.961
|
1.793
|
2.288
|
2.440
|
2.495
|
2.491
|
2.590
|
2.020
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.5890
|
0.5380
|
0.6870
|
0.7320
|
0.7490
|
0.8046
|
0.8535
|
-
|
Announcement Date
|
31/03/20
|
18/03/21
|
18/03/22
|
17/03/23
|
15/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
18,342
|
18,214
|
17,331
|
22,946
|
19,626
|
19,489
|
18,544
|
24,762
|
21,000
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
1,909
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
27/04/23
|
18/08/23
|
30/10/23
|
15/03/24
|
26/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
12,367
|
10,471
|
12,950
|
11,616
|
9,936
|
19,176
|
22,461
|
25,003
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
13.9%
|
11.6%
|
12.8%
|
13%
|
12.1%
|
11.2%
|
10.8%
|
10%
|
ROA (Net income/ Total Assets)
|
5.89%
|
5%
|
5.91%
|
5.63%
|
5.29%
|
5.15%
|
5.3%
|
5.4%
|
Assets
1 |
54,187
|
58,328
|
62,939
|
70,392
|
76,623
|
81,039
|
83,707
|
81,757
|
Book Value Per Share
2 |
14.90
|
16.10
|
17.90
|
19.70
|
21.50
|
23.60
|
25.70
|
27.70
|
Cash Flow per Share
|
-
|
0.3600
|
-
|
-
|
2.520
|
-
|
-
|
-
|
Capex
1 |
2,399
|
870
|
1,248
|
1,382
|
1,615
|
1,295
|
1,384
|
-
|
Capex / Sales
|
3.69%
|
1.41%
|
1.81%
|
1.95%
|
2.14%
|
1.6%
|
1.62%
|
-
|
Announcement Date
|
31/03/20
|
18/03/21
|
18/03/22
|
17/03/23
|
15/03/24
|
-
|
-
|
-
|
Last Close Price
19.52
CNY Average target price
22.06
CNY Spread / Average Target +13.04% Consensus |
1st Jan change
|
Capi.
|
---|
| +25.99% | 661B | | +26.74% | 566B | | -6.64% | 352B | | +18.72% | 332B | | +3.45% | 283B | | +13.43% | 231B | | +4.71% | 200B | | -9.53% | 195B | | -4.33% | 145B |
Other Pharmaceuticals
|